Taiwan eyes vaccine rollout in South America, starting with clinical trials in Paraguay | Taiwan News

2021/07/07 10:17
(Facebook, Medigen Vaccine Biologics Corp. photo)
(Facebook, Medigen Vaccine Biologics Corp. photo)
TAIPEI (Taiwan News) — Medigen Vaccine Biologics Corp., the producer of one of Taiwan’s two home-grown COVID-19 vaccines, announced Tuesday (July 7) that it has officially applied to carry out Phase 3 clinical trials in Paraguay.
The trials will take place at an affiliated hospital of the National University of Asunción in the capital of Paraguayan capital. The country is Taiwan’s only diplomatic ally in South America.
Paraguay's National Health Surveillance Authority (DINAVISA) will determine whether to greenlight the application for clinical trials, which will compare the efficacy of the Medigen and AstraZeneca vaccines through immunobridging, reported CNA.

Related Keywords

Paraguay ,Taipei ,T Ai Pei ,Taiwan ,United States ,America ,Paraguayan , ,Astrazeneca ,Paraguay National Health Surveillance Authority ,Facebook ,Drug Administration ,National University Of Asunci ,Medigen Vaccine Biologics Corp ,Taiwan News ,Medigen Vaccine Biologics ,National University ,National Health Surveillance Authority ,Taiwan Food ,பராகுவே ,தைப்பே ,டி ஐ பேய் ,டைவாந் ,ஒன்றுபட்டது மாநிலங்களில் ,அமெரிக்கா ,பராகுவேயன் ,முகநூல் ,டைவாந் செய்தி ,தேசிய பல்கலைக்கழகம் ,டைவாந் உணவு ,